Neurogenesis-Promoting Natural Product α-Asarone Modulates Morphological Dynamics of Activated Microglia by Qing Cai et al.
ORIGINAL RESEARCH
published: 09 December 2016
doi: 10.3389/fncel.2016.00280
Frontiers in Cellular Neuroscience | www.frontiersin.org 1 December 2016 | Volume 10 | Article 280
Edited by:
Chao Deng,
University of Wollongong, Australia
Reviewed by:
Stefania Ceruti,
University of Milan, Italy
Dennis Qing Wang,
Third Affiliated Hospital of Sun Yat-sen
University, China
*Correspondence:
Gang Pei
gpei@sibs.ac.cn
†
These authors have contributed
equally to this work.
Received: 08 September 2016
Accepted: 21 November 2016
Published: 09 December 2016
Citation:
Cai Q, Li Y, Mao J and Pei G (2016)
Neurogenesis-Promoting Natural
Product α-Asarone Modulates
Morphological Dynamics of
Activated Microglia.
Front. Cell. Neurosci. 10:280.
doi: 10.3389/fncel.2016.00280
Neurogenesis-Promoting Natural
Product α-Asarone Modulates
Morphological Dynamics of Activated
Microglia
Qing Cai 1, 2 †, Yuanyuan Li 1, 2 †, Jianxin Mao 1, 2 and Gang Pei 1, 3*
1 State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences,
Chinese Academy of Sciences, Shanghai, China, 2Graduate School, University of Chinese Academy of Sciences, Chinese
Academy of Sciences, Shanghai, China, 3 School of Life Science and Technology, and the Collaborative Innovation Center for
Brain Science, Tongji University, Shanghai, China
α-Asarone is an active constituent of Acori Tatarinowii, one of the widely used
traditional Chinese Medicine to treat cognitive defect, and recently is shown to
promote neurogenesis. Here, we demonstrated that low level (3 µM) of α-asarone
attenuated LPS-induced BV2 cell bipolar elongated morphological change, with
no significant effect on the LPS-induced pro-inflammatory cytokine expressions. In
addition, time-lapse analysis also revealed that α-asarone modulated LPS-induced
BV2 morphological dynamics. Consistently a significant reduction in the LPS-induced
Monocyte Chemoattractant Protein (MCP-1) mRNA and protein levels was also detected
along with the morphological change. Mechanistic study showed that the attenuation
effect to the LPS-resulted morphological modulation was also detected in the presence
of MCP-1 antibodies or a CCR2 antagonist. This result has also been confirmed in primary
cultured microglia. The in vivo investigation provided further evidence that α-asarone
reduced the proportion of activated microglia, and reduced microglial tip number and
maintained the velocity. Our study thus reveals α-asarone effectively modulates microglial
morphological dynamics, and implies this effect of α-asarone may functionally relate to
its influence on neurogenesis.
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INTRODUCTION
Since ancient time, the applications of naturally existing herbs effectively treating memory
deteriorations and cognitive declines had been well-documented in the Traditional Chinese
Medicine (Park et al., 2002; Yao et al., 2009; Liu et al., 2011; Zhu et al., 2015). Modern researches on
natural herbs, nowadays, endeavor to scrutinize further into cellular and molecular mechanisms.
One famous example is the formulated prescription Smart Soup (SS) (Hou et al., 2014),
which efficiently ameliorates memory deficit. Treatment with SS improved Alzheimer’s disease
Abbreviations: AD, Alzheimer’s disease; APP, amyloid precursor protein; AT, Acori Tatarinowii; CCR2, C-C chemokine
receptor type 2; CNS, central nervous system; dpf, day post fertilization; E. coli, Escherichia coli; ELISA, enzyme-linked
immuosorbent assay; hpf, hour post fertilization; IL-1β, Interleukin -1 beta; IL-6, Interleukin -1 6; LB, Luria Bertani; LPS,
lipopolysaccharides; MCP-1, monocyte chemoattractant protein; MIP-1α, macrophage inflammatory protein 1-alpha; NPC,
neural progenitor cell; PS1, preseninlin 1; qPCR, quantitative polymerase chain reaction; ROCK II, Rho associated coiled-coil
containing protein kinase II; SS, smart soup; Tg, transgenic.
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(AD)-related symptoms in APP/PS1 mice. Acori Tatarinowii
(AT) as one of the three herbs constitute the formula in particular
exhibits neuron-protective effect (Lee et al., 2003; Lin et al., 2012).
Further investigation in this natural herb revealed its major active
constituent asarone exists as stereoisomers (α- and β-asarone),
both of which promoted neurogenesis in AD model mice (Mao
et al., 2015). Moreover, it was also reported that α-asarone
displayed anti-inflammatory effect in the LPS-activatedmicroglia
as well as in the Parkinson’s model mice (Kim et al., 2015).
Such dual-functional product may serve great advantages in the
treatment of AD. As it is well known that activated microglia
mediates inflammation in the central nervous system (CNS)
(Olson and Miller, 2004; Prinz et al., 2006; Graeber et al.,
2011), and the activation of which is accompanied by changes in
cell morphology and motility (Hanisch and Kettenmann, 2007;
Liaury et al., 2012). Therefore, it is of our interest to further
explore the effect of α-asarone on microglial behavior, including
morphology and motility, both of which contribute to the anti-
inflammation mechanism.
At the present, microglia morphology and motility change in
response to inflammatory stimuli had been reported in many in
vitro studies (Rangroo Thrane et al., 2012; Gyoneva et al., 2014).
In addition to these findings, it is of great importance to explore
how microglia behave in their endogenous niche. To achieve
this, we took the advantage of zebrafish larva. The transparent
larval brain and previously established transgenic lines enabled
extensive visualization of fluorescently labeled microglia in
living zebrafish brain. In combination with our well-established
three-dimensional morphology analysis and time-lapse confocal
imaging technology, in vivo researches of microglial dynamics in
zebrafish optic tectum are achievable (Li et al., 2016).
In this study, we compared the LPS- and E. coli-induced in
vitro and in vivo responses as results of α-asarone modulation.
We showed α-asarone exhibited an opposing effect to the LPS-
induced behavioral change, and the morphological changes
may be linked to MCP-1 expression. Our results revealed that,
in comparison to the pro-inflammatory cytokine expressions,
microglia behavioral responses are more sensitive to changes in
the inflammatory stimuli.
MATERIALS AND METHODS
Animals
The present study was performed in strict accordance with the
guidelines of the Institute of Biochemistry and Cell Biology,
Chinese Academy of Sciences. All experimental protocols were
approved and overseen by the Animal Care and Use Committee
of the Shanghai Institute of Biochemistry and Cell Biology,
Chinese Academy of Sciences. All mice were maintained in
pathogen-free conditions.
Cell Culture and Treatment
BV2 cells were cultured and maintained in Dulbecco’s Minimal
Essential Medium (DMEM), supplemented with 10% fetal
bovine serum (FBS) and 100U/ml penicillin and 0.1 mg/ml
streptomycin. Primary microglia cells were prepared from wild
type SD rat on postnatal day 1. In brief, the mixed rat brain
region including cortex and hippocampus was dissected and
the meninges were carefully removed. The brain tissues were
dissociated into single cells by gentle scissoring and pipetting.
The resultant cell suspension was seeded to a T75 flask with
DMEM supplemented with 10% FBS and 100U/ml penicillin and
0.1mg/ml streptomycin. Microglial cells were isolated from the
astrocyte monolayer sheet by shaking.
In all cell-based assays, BV2 and primary microglia cells were
pre-treated with α-asarone (Fluka) at various concentrations
(0.3–100µM) for 2 h, followed by 0.1 or 1µg/ml LPS (055:B5,
Sigma) stimulation for further 24 h.
Immunocytochemistry
BV2 cells and cultured rat microglia cells were fixed with 4%
PFA in PBS for 15min at room temperature, followed by 30
min blocking in PBS containing 1% BSA and 0.1% Triton X-100.
The cultured rat microglia cells were incubated with anti-Iba1
(1:1000, WAKO) primary antibody for 2 h at room temperature,
and Cy3-conjugated anti-rabbit IgG (1:1000) secondary antibody
for 1 h avoiding light exposure. BV2 cells were incubated with
PE-conjugated CD86 (1:100) or APC-conjugated CD80 (1:100)
antibodies overnight at 4◦C, avoiding light exposure. Afterwards,
cells were stained with DAPI (1:1500) for 10min at room
temperature.
Cell Viability Assay
The cytotoxicity potential of α-asarone were examined in the
presence and absence of LPS. BV2 cell viability was tested
using the CellTiter-Glo luminescent cell viability assay (Promega)
following the manufacturer’s instructions.
Scratch Assay
BV2 and primary microglial cells were grown in 48-well plates
till 80% confluent. The monolayer of cells was then wounded
with a sterile 200µl pipette tip, and washed three times with
sterile PBS. Afterwards, the cells were incubated with α-asarone
(0.3, 3, and 100µM) in the presence and absence of LPS for
24 h. Additionally, primary microglia cells were stained with
CellTraceTM CFSE Cell Proliferation Kit (Invitrogen C34554)
before microscopic imaging.
Cell Imaging and Morphological
Characterization
BV2 cells were seeded into 24-well plates at appropriate densities.
The LPS and α-asarone treatments were applied according to
Section Cell Culture and Treatment. The MCP-1 (Peprotech),
CCR2 antagonist RS504393 (Sigma) and mouse biotinylated
MCP-1 antibody (ELISA, DAKEWE Biotech Company) were
applied with LPS where necessary. At the end of 24-h
treatment, cell images were captured by Zeiss Observer Z1
microscope with 20X objective (Plan-Neofluar 20X/0.4). The
BV2 immunocytochemistry staining images were documented
using Olympus FV1200MFE microscope with UPlanSApo 40X2
(40X/0.95) objective. Primary microglia immunocytochemistry
staining images were captured using Olympus IX51 camera with
20X/0.45 Olympus objective. In the Scratch assay, BV2 cells
and primary rat microglia cells migrated into the open area
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was imaged by Zeiss Observer Z1 microscope with Zeiss Plan-
Neofluar 5X and 20X objectives (Plan-Neofluar 5X/0.16, Plan-
Neofluar 20X/0.4).
For morphological analysis, only the single distinct cells were
selected. Dividing cells and cells attached to others were not
included. Image data were processed by Fiji ImageJ software
(Version 2.0.0). The following parameters were quantified: cell
area, perimeter, Feret’s diameter (the longest distance between
any two points along the selection boundary) and circularity
(4pi Area
Perimeter2
). For BV2 cell CD86 and CD80 expressions, the
integrated intensities of each single distinct cell were measured,
the MFI (mean fluorescent intensity) levels were calculated with
respect to the “Short” and “Long” morphologies.
ELISA Determination of IL-6 and MCP-1
For ELISA assays, the supernatants from each treatment were
collected and stored at −20◦C if not used immediately. Prior
to the assay, the supernatant was centrifuged to remove
cellular debris, and diluted by an appropriate factor. IL-6 and
MCP-1 expression were determined using mouse-specific pre-
coated ELISA kits (DAKEWE Biotech Company) according to
manufacturer’s instructions.
RNA Isolation and Reverse Transcription
Total RNA was extracted from BV2 cells using the TRI
Reagent R© (Sigma) following the manufacturer’ s instructions.
Purity and integrity of the RNA was assessed by NanoDrop 1000
Spectrophotometer (Thermo Scientific) and stored at −80◦C
if not for immediate use. The first-strand cDNS synthesis
was performed using the TIANScript M-MLV kit (TIANGEN)
following manufacturer’s instruction. The synthesis was carried
out with the addition of rRNasin R© (Recombinant rRNasin R©
Ribonuclease Inhibitor, Promega).
Quantitative Real-Time Reverse
Transcription-Polymerase Chain Reaction
(qRT-PCR)
ThemRNAs expression was determined by quantitative real-time
PCR using the 2x HotStart SYBR Green qPCR Mater Mix kit
(ExCell). Each reaction was performed in duplicates, and the
supermix contained 4µl pre-diluted cDNA and 0.25µMprimers
in a total volume of 25µl. The reaction parameters were as follow:
10-min of a 95◦C cycle following 40 cycles of denaturation (95◦C
for 30 s), annealing (60◦C for 30 s) and extension (72◦C for 30 s).
An additional cycle was performed for evaluation of primer’s
dissociation curve at 95◦C for 1min, 60◦C for 30 s and 95◦C for
30 s. Primer sequences used in the experiments are listed in the
Supplementary Table 1.
In vitro Time-Lapse Imaging Analysis of
Microglia Morphological Dynamics
BV2 cells were seeded into the 96-well glass bottom black plate.
After 18 h, cells were treated with LPS and α-asarone according to
Section Cell Culture and Treatment. The plate was imaged using
the Cellomics ArrayScan VTI 700 (Thermo Scientific, Pittsburgh,
PA, USA) with 20X objective under bright field. For each well,
real-time images were captured from 16 adjacent fields at each
time point, at 10-minute intervals for 24 h. During the course,
cells were maintained at 37◦C with 5% CO2. For data processing,
each single distinct cell was selected. The long cell number,
motility, cell area and circularity parameters were analyzed using
Fiji ImageJ (version 2.0.0).
In vivo Time-Lapse Imaging Analysis of
Motility and Morphological Dynamics
Zebrafish Embryos
Zebrafish and embryo were maintained at 28.5◦C in a 14/10
light/dark cycle (Kimmel et al., 1995). To inhibit pigmentation,
0.003% PTU was added at 24 h post fertilization (hpf).
Bacterial Infections
Escherichia Coli (E. coli) strain containing pQE801 plasmid
expression tdTomato were grown in LB medium with 100µg/ml
Ampicillin at 37◦C. For infections, 1ml overnight cultures were
centrifuged for 3min at 5000 rpm, and washed and re-suspended
in 1ml PBS. Bacteria were injected directly into the optic tectum
of embedded larva, and images were captured 60min after the
injection, for the duration of 1 h.
In vivo Time-Lapse Confocal Imaging
For live imaging, 5-dpf larvae were embedded in 1.5% low
melting-point agarose (Sigma) at 28.5◦C automatic thermostats.
Larvae were placed in a dorsal view without anesthetics. Images
were carried out under a Zeiss 40×NA 0.80 water immersion
objective with an Olympus FV1000 upright confocal microscope
(473 nm, 543 nm; Japan). The image stacks were in the range of
40–65 µm in depth, captured at 1µm/optical section at a 5-min
interval.
Image Analysis
Resting state morphological dynamics were analyzed as
previously described (Li et al., 2012, 2016). The cell area, tip
number, deformation speed and migration velocity of microglia
were measured by the Fiji ImageJ (version 2.0.0). The tip number
is also referred to as microglial processes or brunch number.
Deformation speed is defined as ∆Area
(Area×∆t)
. Velocity here referred
to the speed of microglia migrating toward E. coli.
Statistics
Statistical analysis was performed using GraphPad Prism 6
software (Graphpad Software, La Jolla, CA, USA). Results were
analyzed by unpaired two-tailed Student’s t-test to determine
the significance of treatment sets. For group comparisons, two-
way ANOVA analysis of variance was performed. All data were
presented as mean ± SEM. P < 0.05 was considered to have
significant difference.
RESULTS
α-Asarone Treatment Attenuates
LPS-induced Microglia Morphological
Changes
Previously, α-asarone was reported to promote neuronal
progenitor cells (NPC) proliferation (Mao et al., 2015). We
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first confirmed that α-asarone (0.3–100µM) did not promote
BV2 microglia proliferation in the presence and absence
of LPS stimulation (Supplementary Figure 1). The results
also indicated that α-asarone did not exhibit cytotoxicity.
Therefore, we proceeded to characterize the effect of α-
asarone on microglia morphology. We examined the BV2 cell
morphological changes at basal and LPS-stimulated conditions.
First, we noticed the cell morphology changed with respect
to differential treatment conditions (Figure 1A). We defined
the “short” and “long” cells and recorded the proportion
of each morphological type within the cell population. The
results showed majority of cells under untreated control and
FIGURE 1 | α-asarone treatment attenuates LPS-induced microglia morphological changes. BV2 microglia morphological changes were characterized (A)
BV2 microglia showed differential morphologies with respect to changing treatment conditions. Black arrowhead, defined as “short” morphology, white arrowhead, as
“long” morphology. (B) The ratio of short and long morphology in a cell population after treatments with α-asarone (0.3, 3, and 100 µM) in the presence and absence
of LPS. Stimulation with LPS led to an increased population of cells in long morphology. α-asarone attenuated the LPS-induced morphological changes. (C–F) Four
parameters characterizing microglial morphology: Area (C), Perimeter (D), Feret’s diameter (E), and Circularity (F). The CD86 and CD80 activation marker expressions
were determined in “long” and “short” cells (G). A representative image of CD86 was shown, with DAPI in cyan and CD86 in magenta. Both CD86 and CD80
expressions were up-regulated in “long” cells. Asterisks indicates differences compared to “Control” (*p < 0.05, **p < 0.01, ****p < 0.0001), crosshatches indicates
differences compared to “LPS” (####p < 0.0001) two-way ANOVA for morphology comparisons between different treatment conditions, n = three independent
experiments. For CD86 and CD80 expressions, the unpaired two-tailed Student t-test were used for comparison between “long” and “short” cells).
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α-asarone treatment alone conditions stayed short (Figure 1B).
Stimulation by LPS greatly increased the number of “long” cells.
However, the addition of α-asarone significantly attenuated such
morphological changes in a concentration-dependent manner.
We then further quantitatively defined the morphology using
four parameters: the cell area, perimeter, Feret’s diameter and
circularity (Figures 1C–F). The results were consistent with
the Figure 1B findings. Under the conditions when cells were
stimulated with LPS, α-asarone treatment significantly reduced
cell area, perimeter and Feret’s diameter and circularity, also in
a dose-dependent manner. From this, we raised the question
whether these long cells correspond to the activated microglia.
By immunocytochemistry assay, we examined the CD86 and
CD80 expression in “long” and “short” cells after LPS and α-
asarone treatments as above (Figure 1G). We found significant
increases in both CD86 and CD80 expression in “long” cells
compared with “short” cells, indicating that the “long” cells,
indeed, correspond to the activated microglia. Therefore, these
data implied that α-asarone could attenuate activated microglia
morphological changes.
In addition, we analyzed the morphological changes of
activated BV2 and primary microglia using a wound-healing
model. As previously described, LPS induces microglia migration
toward a scratched wound (Karlstetter et al., 2010, 2011; Lively
and Schlichter, 2013). We created a single uniform scratch
on the monolayer of cells (Supplementary Figures 2A, 3A).
After migrating toward the open wound, the morphology of
each distinct cell within the wounded area was analyzed. We
also determined the proportion of “long” and “short” cells
(Supplementary Figure 2B), and quantitatively defined the cell
area, perimeter, Feret’s diameter and circularity (Supplementary
Figures 2C–F, 3B–E). The results were consistent with Figure 1
findings. For primary cultured microglia, no change in cell
circularity was detected.
Time-Lapse Analysis of LPS-Induced
Microglia Morphological Dynamics
Affected by Treatment with α-Asarone
We further examined the effect of α-asarone on BV2 microglia
morphological dynamics on a 24-h time course. BV2 cells
were pre-treated with 3 µM α-asarone in the presence of LPS
or with 100 µM α-asarone alone. Micrographic images were
documented at 10-min intervals for 24 h. For each well of
a specific treatment condition, we captured images from 16
adjacent fields at each time point. Only data for typical time
points were shown in Figure 2. Stimulation by LPS resulted in
an increasing trend of long cell numbers. The attenuation effect
of α-asarone was displayed from 7 h onwards (Figure 2B). The
differences between the two treatment conditions were most
significant at 24 h. This was consistent with earlier findings
(Figure 1). We also determined the cell area and circularity
parameters (Figures 2C,E). Changes in both parameters were
monitored for 1 h and the results were normalized to the average
of “control.” Only representative data at four specific time-phases
were shown. At 23–24 h time-phase, we detected reduction in cell
area and an increase in the circularity ratio related to the effect of
α-asarone on the LPS-activated cells. In addition, at 5–6 h time
phase, α-asarone showed a tendency to reduce cell area as well
as to increase cell circularity in comparison to LPS stimulation
alone. However, no statistical significance was detected. There
was also no significant difference in motility, which may due
to large variance in the data (Figure 2D). Time-lapse imaging
consistently showed that α-asarone attenuated LPS-induced
microglia morphological changes at 3µM.A representative video
was provided in the supplementary material (Supplementary
Video), on the left panel cells were stimulated with LPS, and the
right panel the LPS-activated cells were incubated in the presence
of 3µM α-asarone.
MCP-1 Correlates with α-Asarone
Modulation of Morphological Dynamics
Previous study reported that between 50 and 250µM, α-asarone
exhibited anti-inflammatory effect on the LPS-stimulated
microglia cells (Kim et al., 2015). Nevertheless, as demonstrated
in Figure 1, the minimum effective concentration of α-asarone
required to modulate the morphology of activated microglia was
3µM, which is significantly lower compared to the previous
report. In order to determine whether the morphological
modulations of the activated microglia were associated to
the attenuation of inflammatory responses, we analyzed the
expression of various pro-inflammatory cytokines. We found
that 3 µM α-asarone did not inhibit the pro-inflammatory
cytokine IL-1β and IL-6 mRNA expressions (Figures 3A,B).
Protein level detection by ELISA showed consistent results.
Increasing α-asarone concentration (above 30 µM) indeed
resulted in the inhibition of LPS-stimulated IL-6 expression
(Figure 3F). In addition, we confirmed these findings using
0.1 µg/ml LPS as in the previous report (Kim et al., 2015)
(Supplementary Figure 4). Our results were also consistent
with the previous study, such that at high concentrations (100
and 300µM) α-asarone significantly reduced the LPS-induced
IL-1β and IL-6 expressions. Meanwhile, lower concentrations
of α-asarone (1 and 3 µM) did not affect IL-1β and IL-6 levels,
consistent with Figures 3A,B. These results implied that the
morphological modulation of activated microglia might not
associate with the attenuation of inflammatory responses.
In order to define a mechanism by which α-asarone
modulated microglia morphological dynamics, we analyzed the
expression of MCP-1, MIP-1α and ROCKII, which were reported
to influence cell migration and morphology (Xu et al., 1996;
Lentzsch et al., 2003;Widera et al., 2004; Yoneda et al., 2012). The
results showed that MCP-1 expression was reduced by α-asarone
in a concentration-dependent manner (Figures 3C,G). The
inhibition of LPS-induced MCP-1 accumulation was observed
when exposed to both low (1–3µM) (Figures 3C,G, 3µM)
and higher concentrations (10–100 µM) (3G, 10, 30, and
100µM) of α-asarone. On the other hand, no significant
changes in MIP-1α and ROCKII expressions where detected
(Figures 3D,E). Therefore, MCP-1 was associated with the LPS-
induced morphological changes, and α-asarone may attenuate
such morphological change by regulation of MCP-1 expression.
By using the CCR2 antagonist (10µM RS504393) or MCP-1
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FIGURE 2 | Time-lapse analysis of LPS-induced microglial morphological dynamics affected by treatment with α-asarone. Microglia morphological
dynamics were analyzed over a 24-h time course by Cellomics ArrayScan. Images were captured at 10-min intervals. Representative images were shown for each
treatment condition (A). Basal level morphological modulations by 100 µM α-asarone were examined. LPS stimulation resulted in an increase in the number of long
cells over time, whilst α-asarone (3 µM) stabilized the increase (B). The differences were most significant at the end of 24 h. The cell area (C) and circularity (E) were
determined at four representative time phases. Results were normalized to “Control.” The effect of α-asarone on the LPS-induced morphological changes was most
significant at “23–24”-h time phase. In addition, LPS displayed a trend to increase cell motility compared with α-asarone (3 µM) pre-treatment condition (D). Asterisks
indicates differences compared to “Control” (**p < 0.01, ***p < 0.001), crosshatches indicates differences compared to “LPS” (###p < 0.001) two-way ANOVA test
for at least three independent data comparisons, n ≥ 3).
antibody, we confirmed on the inhibitions of LPS-induced
morphological changes (Figures 3H–K).
Inversely, the addition of MCP-1 (100 ng/ml) retained the
LPS-resulted microglia morphological change in the presence of
α-asarone. We recorded an increase in the long cell numbers
associated with MCP-1 even in the presence of α-asarone
treatment (Figure 3L). Concomitantly, changes in cell area,
perimeter, Feret’s diameter and circularity parameters together
demonstrated an opposing effect of MCP-1 to α-asarone
(Figures 3M–P). These results served clear indications that the
attenuation by α-asarone to LPS-induced morphological changes
was effectively rescued by MCP-1.
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FIGURE 3 | MCP-1 correlates with α-asarone modulation of morphological dynamics. The effect of α-asarone on the BV2 microglia pro-inflammatory cytokine
(A,B,F) and chemokine (C–E,G) expressions were determined. α-Asarone (3 µM) significantly inhibited the LPS-induced MCP-1 production (qPCR, C and ELISA, G).
Low concentrations of α-asarone (1–3 µM) did not inhibit the pro-inflammatory cytokine expressions (A,B). Higher concentration of α-asarone (30 and 100 µM)
showed inhibitory effect on the pro-inflammatory cytokine expression (F). MCP-1 depletion (MCP-1 antibody) or antagonizing CCR2 receptors (RS504393) modulated
BV2 morphology (H–K), the effects were comparable to α-asarone. The MCP-1 (100 ng/ml) rescued the LPS-induced BV2 morphological changes in the presence of
α-asarone (L–P). Changes in the number of long cells were recorded (L), and microglia morphology was characterized: cell Area (M), Perimeter (N), Feret’s diameter
(O), and Circularity (P). Asterisks indicates differences compared to “Control” (***p < 0.001, ****p < 0.0001), crosshatches indicates differences compared to “LPS”
(#p < 0.05, ##p < 0.01, ###p < 0.001, ####p < 0.0001), pound symbol indicates differences compared to “LPS + a-asarone” (£p < 0.05, ££p < 0.01,
££££p < 0.0001) two-way ANOVA test for three independent data comparisons, each performed in duplicates, n = 3).
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Modulation by α-Asarone on LPS-Induced
Morphological Changes Is Rescued by
MCP-1 in Primary Microglia
In order to validate our findings, we examined the
morphological changes in primary rat microglia. We first
confirmed the α-asarone effect on IL-1β, IL-6, and MCP-
1 expressions (Figures 4A–C). The results showed that at
higher concentrations (100 and 300µM), α-asarone inhibited
the accumulation of LPS-induced IL-1β, IL-6, and MCP-
1 expressions. At lower concentration (3µM), α-asarone
specifically reduced the LPS-induced MCP-1 expression. These
results correlated with the findings in BV2 cells. Subsequent
morphological analysis revealed that untreated microglial
cells maintained relatively small somata sizes, as defined by
the cell area (Figures 4D,E). Stimulation by LPS resulted in a
significant enlargement in cell area, and the reverse effect was
observed when α-asarone was applied. Nevertheless, α-asarone
attenuation on the LPS-induced somata enlargement was
effectively rescued by MCP-1 (Figures 4D,E). We also detected
significant increase in cell perimeter and Feret’s diameter in
the presence of LPS stimulation (Figures 4F,G). In addition,
co-treatment with α-asarone showed a decreasing trend in both
parameters, but the difference for Feret’s diameter measurement
was not significant. In addition MCP-1 rescued cell perimeter
and Feret’s diameter in the presence of α-asarone. Finally, no
significant changes in cell circularity were detected under all
conditions (Figure 4H). These results confirmed that α-asarone
attenuation on LPS-induced morphological changes was rescued
by MCP-1.
α-Asarone Affects Microglia Morphological
Dynamics In vivo
To determine the role of α-asarone in microglia in vivo,
transgenic line Tg(Apo-E:eGFP) with microglia in green was
used (Li et al., 2012). First of all, zebrafish embryos were
treated with 0.3–3 µM α-asarone from 12 hpf to 5 dpf, and no
developmental defects were observed under these concentrations
(Supplementary Figure 5A). Therefore, we treated zebrafish
embryos with 3 µM α-asarone in the presence and absence
of E coli from 4 dpf for 24 h, and examined the morphology
and dynamics of only resting microglia. The in vivo time-lapse
imaging was carried out at 5-min intervals for 60 min according
to previous study (Li et al., 2016). No significant difference was
observed in the resting microglia cell area, deformation speed
and tip number (Supplementary Figures 5B–G). Subsequently,
we analyzed the activated microglia dynamics by injection
of the red-fluorescent E. coli into the gap at the optic
tectum region (Figure 5A), and images were then captured
(Figure 5B). Following the previous description for microglia
states (Kettenmann et al., 2011), we examined the percentage
of active-state microglia in the presence of α-asarone. The
results showed a remarkable decrease (control vs. α-asarone
79.4 ± 5.3 vs. 59.6 ± 6.9, p < 0.05, Figure 5C). Quantitative
analysis of active microglia morphological dynamics showed
that the effect of α-asarone to the average velocity of microglia
cells was not statistically significant. However, the effect in
the overall trend was significant, which indicated α-asarone
maintained the activated microglial migration velocity (p <
0.01, Figures 5D,E). Further analysis revealed that α-asarone
treatment led to approximately 50% decrease in the average tip
number (asarone 53% ± 7% of control, p < 0.05, Figure 5G)
without changes in the cell area (asarone 105% ± 4% of control,
p = 0.55, Figures 5H,I). In addition, the dynamical changes of
tip numbers change over the 60-minute time course also showed
significant difference with relation to α-asarone treatment (p <
0.0001, Figure 5F). These results suggested that α-asarone might
affect the microglia activation and function without modulating
the resting state dynamics.
DISCUSSION
In this study, we showed the anti-inflammatory effects of
a natural product and sought to unravel the underlying
link between its anti-inflammation and the previously
studied neurogenesis-promoting effect. Uncontrolled
neuroinflammation accompanied with aberrant neurogenesis
were observed in the pathogenesis of neurodegenerative
diseases. Interestingly, a number of clinical drugs exhibit dual
functions, and simultaneously modulate neuroinflammation
and neurogenesis (Malberg et al., 2000; Kotani et al., 2006;
Tchantchou et al., 2007; Hwang et al., 2010; Ji et al., 2014; Wan
et al., 2016). The use of these “dual-functional” drugs might bring
a greater advantage in targeting neurodegenerative diseases. In
addition to these, other drugs may exhibit anti-inflammatory and
anti-mitochondrial impairment functions, which sequentially
serve as effective neuroprotective reagents (Xu et al., 2013;
Chen et al., 2015; Wei et al., 2016). For example, simvastatin
(Xu et al., 2013; Gao et al., 2016; Zhou et al., 2016) and
memantine (Xu et al., 2012; Wei et al., 2016) used in Parkinson’s
diseases, attenuate the 6-OHDA-induced inflammation and
Nur77 cytosolic translocation. The consequences of which
eventually lead to suppression of neurodegeneration and to
promote survival signaling. As previously described by Kim
et al. (Kim et al., 2015), α-asarone suppressed the production
of pro-inflammatory cytokines by LPS-activated microglia in
the Parkinson’s disease model mice. On the other hand, Mao
et al. (Mao et al., 2015) showed that α-asarone promoted adult
hippocampal NPC proliferation. Therefore, we chose α-asarone
in our research conceptually as a representation of compounds
which simultaneously possessing dual functions.
Besides of pro- and anti-inflammatory cytokines produced by
microglia, changes in microglia behavior in terms of motility and
morphological dynamics are also implicated in the pathological
conditions. During inflammation, microglia change morphology
frequently, and activation of microglia leads to movement
toward the site of injury and inflammation (Lull and Block,
2010; Saijo and Glass, 2011). Interestingly, we found differential
effects of α-asarone on pro-inflammatory cytokine production
and microglia behavior when applied at distinctive doses.
At low concentration (3µm), α-asarone modulated LPS- or
E. coli—stimulated microglia morphological dynamics as well
as attenuated activation, yet no significant effect on the pro-
inflammatory cytokine expressions was detected. We used both
in vitro and in vivo models to confirm this finding. The changes
in the activated BV2 morphologies were most obvious. In the
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FIGURE 4 | Modulation by α-asarone on LPS-induced morphological changes is rescued by MCP-1 in primary microglia. The effect α-asarone treatment
on the 0.1 µg/ml LPS-induced IL-1β (A), IL-6 (B), and MCP-1 (C) expression in rat primary microglial cells. The microglial morphological changes were characterized
after immunocytochemistry staining. Untreated microglia cells showed smaller somata (D). Four parameters define microglial morphology: cell Area (E), Perimeter (F),
Feret’s Diameter (G), and Circularity (H). Asterisks indicates differences compared to “Control” (**p < 0.01, ***p < 0.001, ****p < 0.0001), crosshatches indicates
differences compared to “LPS” (#p < 0.05, ##p < 0.01, ####p < 0.0001), pound symbol indicates differences compared to “LPS + a-asarone” (£p < 0.05,
££££p < 0.0001) two-way ANOVA test for five independent data comparisons, n = 5).
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FIGURE 5 | α-asarone affects microglial morphological dynamics in vivo. E. coli was inject into the gap the optic tectum region (A) of the transgenic
Tg(Apo-E:eGFP) zebrafish. Time-lapse images were taken at 5-min intervals (B). Zebrafish pre-incubated with α-asarone showed decreased activation, n = 3 (C). The
pre-treatment did not cause significant effect to the average migration velocity (E), but the dynamics of velocity change was significant (D). Results were normalized to
“0 min” value. α-asarone treatment resulted significant declines in both dynamical changes and average numbers of tips (F,G). α-asarone treatment did not affect the
cell area (H,I). (*p < 0.05, unpaired two-tailed Student t-test for independent data comparison vs. E. coli injection; ***p < 0.001, two-way ANOVA for group
comparison between the dynamical trends, the numbers were on the bars).
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primary cultured microglia cells, we detected limited change in
the Feret’s diameter and circularity. This might due to the fact
that the primary microglia adapt more “irregular” and “varied”
morphologies compared to BV2 cells. The morphologies of
primary microglia may not simply be described as “short” and
“long”. In the zebrafish model, we used E. coli to mimic the
response of LPS. α-asarone attenuated activation of microglia
in the in vivo model, which is consistent with our in vitro
findings (Figure 1) as the number of “long” cells was also greatly
reduced. Even though we did not detect changes in cell area,
reduction in the microglia tip numbers indicated significant
changes in cell morphology. Such modulation may provide
implication for reduced phagocytic probability, which in turn
may contributes to attenuation of microglia activation. When
applied at high concentrations (30–100µM), α-asarone, indeed,
suppressed the pro-inflammation cytokine production, which
is consistent with the previous report. These data implied that
microglia morphological changes might be a more sensitive
and rapid response to environmental stimulation. Therefore,
microglia behavior changes may serve as an early indication for
anti-inflammatory actions of therapeutic agents.
Secondly, we observed a link between the expression of
MCP-1 and the effects of α-asarone on microglia morphological
dynamics. We recorded a dose-dependent modulation in the
LPS-induced MCP-1 level by α-asarone. Further, reduction in
MCP-1 expression led to changes in the microglia morphological
dynamics similar to α-asarone treatment, whilst the addition of
MCP-1 rescued the LPS-induced morphological changes even
in the presence of α-asarone. Therefore, α-asarone modulation
of the LPS-induced microglia morphological changes may be a
result of regulation of MCP-1 expression. MCP-1 was reported
to enhance chemotaxis of cells toward site of inflammation
and injuries (Ajuebor et al., 1998; Ashida et al., 2001; Arefieva
et al., 2005; Hoh et al., 2011). Besides, MCP-1 contributes to
the actin cytoskeleton rearrangement and redistribution of the
tight junction protein such as occludin and claudin-5 (Stamatovic
et al., 2003; Song and Pachter, 2004; Lee et al., 2009; Strecker et al.,
2013), which are closely related to morphology changes. MCP-
1 expression is mainly regulated by NF-κB/IκB, p38/ERK1/2
and Akt pathways, although this may also be influenced by the
ambient cytokine concentrations (Takaya et al., 2003; Skalniak
et al., 2009). The accumulation of MCP-1 in turn plays a positive
feedback role (Werle et al., 2002; Skalniak et al., 2009; Yang
et al., 2014), enabling a well-balanced and precise regulation for
MCP-1. The mechanism by which α-asarone down-regulates the
LPS-induced microglia pro-inflammatory cytokine release might
overlap with MCP-1 regulatory pathways on NF-κB/IκB. It thus
explains the α-asarone inhibition of MCP-1 accumulation.
Microglia are one of the major components of NPC niche
and regulate neurogenesis in adult hippocampus (Gemma and
Bachstetter, 2013; De Lucia et al., 2016). In the physiological
conditions, surveillance microglia secrete trophic factors,
such as the Insulin-like growth factor and Brain-derived
neurotrophic factor, both of which are essential to neurogenesis
(Lazarini et al., 2012; Matsuda et al., 2015). However, under
pathological conditions, activation of microglia produces pro-
inflammatory cytokines that lead to aberrant neurogenesis.
At the concentration, which Mao et al previously reported to
promote NPC proliferation (1–10µM), we did not observe
changes in the pro-inflammatory cytokines expression by
α-asarone treatment. Therefore, it needs to be determined
whether modulations in microglia morphology and MCP-1
expressions functionally correlate with NPC proliferation and
neurogenesis, and vice versa. Interestingly, it was reported that
MCP-1 exhibited neuroprotective function (Eugenin et al.,
2003) and restored the number of retinal ganglion cell in the
experimental glaucoma model with the concentration of MCP-1
being rather critical (Chiu et al., 2010). This probably serves an
explanation to the tight regulation of MCP-1 expression. Finally,
although it has not to date been generally confirmed whether
most “dual-functional” drugs and compounds also influence
microglia behavior, they might represent an innovative approach
against neurodegenerative diseases.
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